Stock data

杏輝 (1734)

杏輝 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$254.43M, down 22.5% from a year earlier. EPS over the last four quarters totals NT$1.79.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 杏輝 in Insightr